Francesco De Santis and Italfarmaco
Francesco De Santis enters in Italfarmaco in 1981 at the age of 25 and has been covering during his career the different positions of Managing Director, Director of the Board, President of Italfarmaco Spa and is President of Italfarmaco Holding. He has personally driven the foundation and internationalization process of all of the Group’s companies.
"My father lumped his company with that of another family together, whose shares he then took over. He was a pioneer in the 1970s. But ours remains a family business that my brother Claudio and I own today. There are six young people of the third generation that we have trained to become the responsible and future shareholders, as it was our duty."
Francesco De Santis, Corriere Economia, 2021
THE RESILIENCE OF PHARMA A MODEL FOR THE WHOLE INDUSTRY
It was a year lived in the midst of many difficulties. "But there was no patient left without drugs because the pharmaceutical industry continued to produce. This will be the only industrial sector in Italy to close 2020 with stable production levels, perhaps even growing, when many other sectors will be negative. The pharmaceutical industry thus confirms itself once again as one of the backbones of the country."
The recipe? "Focusing on high value-added productions, on light factories with a moderate environmental impact thanks to technology" ... "Finally, there is the international vision, mandatory since the birth of a company."
“Our heparin in the global challenge at Covid. The hematology sector is worth 20% of Italfarmaco's turnover and these drugs are a piece of company history as we have been producing them since 1974 ... The other key sector for us is the health of women who with gynecology, pregnancy, contraceptives and anemias account for over a quarter of revenues."
Francesco De Santis, Corriere Economia, 18 gennaio 2021
Statements & Interviews »